KALAMAZOO, Mich.–West Michigan Cancer Center & Institute for Blood Disorders (WMCC) and Sturgis Hospital have formed a clinical partnership that will expand patients’ access to advanced cancer care, innovative clinical trials and survivorship resources in St. Joseph County.
“We’re very pleased to collaborate with the West Michigan Cancer Center,” said Rob LaBarge, Sturgis Hospital President and CEO. “The fine reputation of the WMCC and its medical staff is well known. Combining their expertise with our compassionate staff will ensure our patients will receive the very best of care.”
WMCC’s new Sturgis campus is based at the hospital at 916 Myrtle Avenue. Patient care is provided by Muhammad Rafi, MD, and Dustin Bivins, MD, both WMCC hematologists and medical oncologists.
“We thank the dedicated staff at Sturgis Hospital for their efforts to work with us to continue providing state-of-the-art cancer care in St. Joseph County,” said Joseph Mirro, M.D., CEO/CMO of West Michigan Cancer Center & Institute for Blood Disorders.
“We’ve taken the time to consider all our options for oncology services,” said LaBarge, “and we are confident this partnership is the absolute best choice for our patients.”
WMCC is a not-for-profit collaboration of Borgess Health and Bronson Healthcare Group, founded in 1994. The center also operates affiliate clinics in Allegan, Dowagiac, Marshall, South Haven, and Three Rivers, seeing approximately 4,000 new patients annually.